Braiin Ltd (NASDAQ:BRAI – Get Free Report) shares gapped down prior to trading on Wednesday. The stock had previously closed at $3.07, but opened at $2.80. Braiin shares last traded at $2.8430, with a volume of 335,145 shares trading hands.
Key Stories Impacting Braiin
Here are the key news stories impacting Braiin this week:
- Neutral Sentiment: Recent coverage discusses brain and health research, including Alzheimer’s disease and brain imaging; it does not mention Braiin or provide a direct stock catalyst. New brain atlas article Stanford MRI project article
- Neutral Sentiment: Other stories cover general health and lifestyle topics such as digestion, sleep, and perimenopausal brain fog, with no reported business or financial developments involving BRAI. Gut-brain connection article Deep sleep and memory article
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Braiin in a report on Monday, August 3rd. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Braiin presently has a consensus rating of “Hold” and a consensus price target of $10.00.
Get Our Latest Analysis on BRAI
Braiin Trading Down 17.9%
The business’s 50-day moving average is $4.80 and its two-hundred day moving average is $6.41.
Braiin Company Profile
Braiin Limited is an Australia-based company focused on agriculture, biosecurity and technology. The company develops and provides products, services and data-driven solutions intended to support agricultural productivity, animal health and environmental management.
Braiin’s activities include agricultural and livestock-related solutions, pest and biosecurity management, and technology designed to help customers monitor operations and improve decision-making. Its offerings are aimed primarily at agricultural, rural and environmental applications.
The company serves customers in Australia and may operate internationally through its technology and agricultural businesses.
Recommended Stories
- Five stocks we like better than Braiin
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
- Washington Made a $2 Billion Quantum Bet, But Can Either ETF Match It?
- Bloom Energy: The Off-Grid Answer to AI’s Power Drain
Receive News & Ratings for Braiin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Braiin and related companies with MarketBeat.com's FREE daily email newsletter.
